Skip to content

Vestibular Rehabilitation and Dizziness in Geriatric Patients

Vestibular Rehabilitation and Dizziness in Geriatric Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00275392
Enrollment
39
Registered
2006-01-11
Start date
2006-04-30
Completion date
2009-08-31
Last updated
2014-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dizziness

Keywords

Dizziness, Geriatrics, Rehabilitation, Vestibular rehabilitation

Brief summary

The purpose of this study is to develop effective exercise intervention to reduce dizziness and fall risk in older adults with non-specific dizziness. We hypothesize that the use of vestibular exercises can reduce dizziness and improve gaze and postural stability in older persons.

Detailed description

Community dwelling older individuals who present to a specialty dizziness clinic (Atlanta VAMC or Emory University) with a primary complaint of dizziness will be recruited to participate in this study. Before beginning the study, the presence of normal vestibular function will be measured directly using standard vestibular function tests. Individuals will be randomly assigned to the vestibular exercise group (VR) or to the control group (CON). Data will be collected prior to the initiation of physical therapy and at the completion of the 6-week intervention period. The VR group will perform vestibular exercises plus balance and gait exercises. The CON group will perform saccadic eye movements without targets against a blank wall, as well as balance and gait exercises. The balance and gait exercises for each group will be based on identified impairments and functional limitations, as is the standard of care in physical therapy. All subjects within a group will follow the same exercise progression for the vestibular or eye movement exercises. Subjects will be seen in the clinic on a weekly basis to review and modify the exercises according to a standard protocol and to reinforce compliance.

Interventions

BEHAVIORALVestibular rehabilitation

vestibular adaptation and substitution exercises

BEHAVIORALPlacebo

placebo vestibular exercises

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients must be at least 60 years of age, seeking medical care due to dizziness and have normal vestibular function based on results of the clinical examination, rotary chair and/or caloric tests.

Exclusion criteria

Abnormal vestibular function based on results of clinical examination, rotary chair and/or caloric tests.

Design outcomes

Primary

MeasureTime frameDescription
Dynamic Gait Index6 weeksFall risk was determined using the Dynamic Gait Index (DGI). A maximum total score of 24 is possible and a total score of \< 20 indicates risk for falling.

Secondary

MeasureTime frameDescription
Dynamic Visual Acuity6 weeksVisual acuity during head movement (dynamic visual acuity, DVA) was measured using customized computerized software. DVA is measured in Logarithm of the Minimum Angle of Resolution (LogMAR). Participants identified letters while turning the head from side to side between 120 and 180 deg/s. DVA, the difference in acuity between head stationary and moving, is reported as the average of rightward and leftward scores; higher scores indicate worse visual acuity.

Countries

United States

Participant flow

Participants by arm

ArmCount
Vestibular Rehabilitation
vestibular exercises plus standard balance and gait exercises Vestibular rehabilitation: vestibular adaptation and substitution exercises
20
Placebo
placebo exercises plus standard balance and gait exercises Placebo Vestibular rehabilitation: placebo vestibular exercises
17
Total37

Baseline characteristics

CharacteristicPlaceboTotalVestibular Rehabilitation
Age, Continuous74.5 years
STANDARD_DEVIATION 8.5
73.8 years
STANDARD_DEVIATION 7.5
73.6 years
STANDARD_DEVIATION 6.5
Dynamic Gait Index16.1 units on a scale
STANDARD_DEVIATION 2.6
15.1 units on a scale
STANDARD_DEVIATION 3
14.2 units on a scale
STANDARD_DEVIATION 3.1
Dynamic Visual Acuity0.14 LogMAR
STANDARD_DEVIATION 0.07
0.16 LogMAR
STANDARD_DEVIATION 0.08
0.20 LogMAR
STANDARD_DEVIATION 0.08
Sex: Female, Male
Female
11 Participants28 Participants17 Participants
Sex: Female, Male
Male
6 Participants9 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 19
serious
Total, serious adverse events
0 / 200 / 19

Outcome results

Primary

Dynamic Gait Index

Fall risk was determined using the Dynamic Gait Index (DGI). A maximum total score of 24 is possible and a total score of \< 20 indicates risk for falling.

Time frame: 6 weeks

Population: Per-protocol analyses (i.e., only subjects who completed the intervention were included).

ArmMeasureGroupValue (MEAN)Dispersion
Vestibular RehabilitationDynamic Gait IndexDischarge (6 weeks)18.9 units on a scaleStandard Deviation 1.8
Vestibular RehabilitationDynamic Gait IndexBaseline14.2 units on a scaleStandard Deviation 3.1
PlaceboDynamic Gait IndexDischarge (6 weeks)18.9 units on a scaleStandard Deviation 3
PlaceboDynamic Gait IndexBaseline16.1 units on a scaleStandard Deviation 2.6
p-value: 0.026RM ANOVA
p-value: <0.001RM ANOVA
p-value: >0.05RM ANOVA
Secondary

Dynamic Visual Acuity

Visual acuity during head movement (dynamic visual acuity, DVA) was measured using customized computerized software. DVA is measured in Logarithm of the Minimum Angle of Resolution (LogMAR). Participants identified letters while turning the head from side to side between 120 and 180 deg/s. DVA, the difference in acuity between head stationary and moving, is reported as the average of rightward and leftward scores; higher scores indicate worse visual acuity.

Time frame: 6 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Vestibular RehabilitationDynamic Visual AcuityDischarge (6 weeks)0.14 LogMARStandard Deviation 0.07
Vestibular RehabilitationDynamic Visual AcuityBaseline0.20 LogMARStandard Deviation 0.08
PlaceboDynamic Visual AcuityDischarge (6 weeks)0.19 LogMARStandard Deviation 0.08
PlaceboDynamic Visual AcuityBaseline0.21 LogMARStandard Deviation 0.1
p-value: >0.05RM ANOVA
p-value: 0.016RM ANOVA
p-value: >0.05RM ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026